
Abcam buys Expedeon’s immunology business
“This purchase price is equivalent to twice Expedeon’s current market capitalisation or excess of 9-times 2018 annual group revenue,” the company...

Ermium Therapeutics bags €6.3m in Series A round
Domain Therapeutics, Kurma Partners, Idinvest, and the SATT Erganeo contributed to the financing. Ermium Therapeutics has licenced exclusively...

AMR: GARDP and Entasis Therapeutics start pivotal study
In the open-label study enroling 1,000 patients, safety and efficacy of zoliflodacin will be compared with a combination of azithromycin and...

Pro-apoptotic protein blocks autoimmunity
John Rizk discovered that the SMAC protein (Second mitochondria-derived activator of caspase) besides triggering cancer cell apoptosis have a second...

Magenta Therapeutics exercises ATAC licence option
Stem cell specialist Magenta Therapeutics (Cambridge, MA, USA) agreed to pay up to $85m in milestones for the rights to exclusively develop and...

New method allows tracking of HIV
According to study leaders Prof. Christian Eggeling from Leibniz IPHT, Dr. Cyril Favard and Dr. Delphine Muriaux from the Montpellier Infectious...

Novo secures Dicerna’s RNAi liver assets
Under the deal, which includes potential treatments for NASH, orphan liver diseases, obesity and diabetes, Dicerna could theoretically earn...